Mithra Receives EUR 1.25 Million Milestone Payment from Fuji Pharma under Estelle® Licensing Agreement
August 03, 2023 01:30 ET
|
Mithra Pharmaceuticals
Mithra Receives EUR 1.25 Million Milestone Payment from Fuji Pharma under Estelle® Licensing Agreement Relates to completion of the interim clinical study reports of Phase 3 trials in patients...
Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025
July 17, 2023 11:45 ET
|
Mithra Pharmaceuticals
Notice of Adjustment of the Conversion Price of Mithra's EUR 125,000,000 Senior Unsecured Convertible Bonds due 2025 (ISIN: BE6325746855) Liege, Belgium, 17 July 2023 – 17:45 CEST – Mithra...